BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14866288)

  • 1. [Role of portal hypertension in the pathogenesis of cirrhotic ascites; its demonstration by portal radiomanometry].
    CAROLI J; PARAF A; SCHWARZMANN V
    Sem Hop; 1951 Jun; 27(41):1761-76. PubMed ID: 14866288
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis.
    Gioia S; Nardelli S; Pasquale C; Pentassuglio I; Nicoletti V; Aprile F; Merli M; Riggio O
    Dig Liver Dis; 2018 Aug; 50(8):839-844. PubMed ID: 29429910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory ascites due to portal vein thrombosis in liver cirrhosis--report of two cases.
    Tanaka H; Horie Y; Idobe Y; Murawaki Y; Suou T; Kawasaki H
    Hepatogastroenterology; 1998; 45(23):1777-80. PubMed ID: 9840147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doppler hemodynamic study in portal hypertension and hepatic encephalopathy.
    Perisic M; Ilic-Mostic T; Stojkovic M; Culafic D; Sarenac R
    Hepatogastroenterology; 2005; 52(61):156-60. PubMed ID: 15783018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenic Doppler impedance indices: influence of different portal hemodynamic conditions.
    Bolognesi M; Sacerdoti D; Merkel C; Gerunda G; Maffei-Faccioli A; Angeli P; Jemmolo RM; Bombonato G; Gatta A
    Hepatology; 1996 May; 23(5):1035-40. PubMed ID: 8621130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aneurysmal dilatation of the portal vein: a rare cause of portal hypertension.
    Alexopoulou A; Papanikolopoulos K; Thanos L; Dourakis SP
    Scand J Gastroenterol; 2005 Feb; 40(2):233-5. PubMed ID: 15764157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenesis of ascites in liver cirrhosis; Role of portal hypertension].
    LOURENCO JORGE A
    Rev Bras Med; 1946 Apr; 3():280-5. PubMed ID: 20986289
    [No Abstract]   [Full Text] [Related]  

  • 8. Portal vein omentin is increased in patients with liver cirrhosis but is not associated with complications of portal hypertension.
    Eisinger K; Krautbauer S; Wiest R; Karrasch T; Hader Y; Scherer MN; Farkas S; Aslanidis C; Buechler C
    Eur J Clin Invest; 2013 Sep; 43(9):926-32. PubMed ID: 23855493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascites in cirrhosis. Relative importance of portal hypertension and hypoalbuminemia.
    Castell DO
    Am J Dig Dis; 1967 Sep; 12(9):916-22. PubMed ID: 6039572
    [No Abstract]   [Full Text] [Related]  

  • 10. HEPATIC VASCULAR ANATOMY AND MANOMETRY IN EXPERIMENTAL BILIARY OBSTRUCTION AND ASCITES.
    GLIEDMAN ML; GIRARDET RE; SCHWARTZ A; RYZOFF R; LERNER B; KARLSON KE
    Surg Gynecol Obstet; 1964 Oct; 119():749-57. PubMed ID: 14211207
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
    Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
    Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portal hypertension due to chronic occlusion of the extrahepatic portion of the portal vein: its relation to ascites.
    BAGGENSTOSS AH; WOLLAEGER EE
    Am J Med; 1956 Jul; 21(1):16-25. PubMed ID: 13339809
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathology of idiopathic non-cirrhotic portal hypertension.
    Guido M; Sarcognato S; Sacchi D; Colloredo G
    Virchows Arch; 2018 Jul; 473(1):23-31. PubMed ID: 29644430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sonographic signs in portal hypertension: a multivariate analysis.
    Sharma MP; Dasarathy S; Misra SC; Saksena S; Sundaram KR
    Trop Gastroenterol; 1996; 17(2):23-9. PubMed ID: 8783973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portal and splenic hemodynamics in cirrhotic patients: relationship between esophageal variceal bleeding and the severity of hepatic failure.
    Kayacetin E; Efe D; Doğan C
    J Gastroenterol; 2004 Jul; 39(7):661-7. PubMed ID: 15293137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
    Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
    J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on portal hypertension and ascites in Egyptian cirrhotics. III. A comparative study of the intrasplenic. intrahepatic, and occluded hepatic routes as indices of portal pressure.
    EL-ROOBY A; ATA AA; EL-RAZIKY E
    J Egypt Med Assoc; 1963; 46():1-15. PubMed ID: 13974687
    [No Abstract]   [Full Text] [Related]  

  • 18. EXPERIMENTAL ASCITES. V. PRODUCTION OF HEPATIC OUTFLOW BLOCK AND ASCITES WITH A HEPATIC VEIN CHOKER.
    ORLOFF MJ; BADDELEY RM; ROSS TH; NUTTING RO; THOMAS HS; HALASZ NA; SLOOP RD
    Ann Surg; 1965 Feb; 161(2):258-62. PubMed ID: 14260025
    [No Abstract]   [Full Text] [Related]  

  • 19. [Advances and unmet needs in clinical studies on liver cirrhosis].
    Xu JH; Xu XY
    Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):913-914. PubMed ID: 31941251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal vein velocity by duplex Doppler ultrasound as an indication of the clinical severity of portal hypertension.
    Kuo CH; Changchien CS; Tai DI; Chen JJ
    Changgeng Yi Xue Za Zhi; 1995 Sep; 18(3):217-23. PubMed ID: 8521331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.